No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
397 |
6. Filter based on genotype QC (FinnGen only) |
397 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80-D89
- Name in latin
- Deficientiae immunales mixtae
Similar endpoints
↥List of similar endpoints to
Combined immunodeficiencies
based on the number of shared cases.
Similar with more cases:
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3113 | 1722 | 1368 |
| Only index persons | 2640 | 1511 | 1129 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.04 |
| Only index persons | 0.05 | 0.06 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 56.62 | 54.81 | 58.78 |
| Only index persons | 54.63 | 53.01 | 56.80 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 397 | 242 | 155 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.07 |
| Median age at first event (years) | 54.01 | 49.17 | 61.56 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 365
- Matched controls
- 3650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D81.4
ICD-10 Finland
Nezelof syndrome
+∞
161.8
143
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
107.8
98
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
11.8
69.0
141
184
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.9
53.6
111
140
D81.8
ICD-10 Finland
Other combined immunodeficiencies
+∞
49.1
46
*
ZXD05
NOMESCO Finland
Urgent procedure
4.2
35.0
186
723
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
32.8
31
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
6.6
24.3
66
118
D81.2
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
+∞
20.0
19
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
20.0
19
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
19.5
89
277
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
18.9
18
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.8
18.9
89
284
N02AX02
ATC
tramadol; systemic, rectal
2.7
18.7
195
1077
ZXE10
NOMESCO Finland
More than one and less than three hours
2.7
18.3
178
939
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
17.9
137
619
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
17.4
192
1080
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
17.2
145
694
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
16.8
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
15.7
79
263
J01MA12
ATC
levofloxacin; systemic
3.2
15.5
96
371
Z3226
NOMESCO Finland
Physiotherapist
3.1
15.3
99
396
C03CA01
ATC
furosemide; systemic
2.6
15.2
144
725
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
15.1
48
103
J01FF01
ATC
clindamycin; systemic
2.7
14.9
127
601
P01AB01
ATC
metronidazole; oral, rectal
2.4
13.9
173
998
J01DA01
ATC
[U] cefalexin; systemic
2.4
13.4
250
1746
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
13.3
103
457
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
10.6
13.2
25
25
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.8
13.0
37
70
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
12.9
84
333
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
12.6
12
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
12.2
61
200
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
12.2
101
462
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
11.5
11
*
D81.3
ICD-10 Finland
Adenosine deaminase [ADA] deficiency
+∞
11.5
11
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
11.5
11
*
R50.9
ICD-10 Finland
Fever, unspecified
3.0
11.2
70
267
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
11.1
55
179
J01MA02
ATC
ciprofloxacin; systemic
2.2
11.1
161
969
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
11.0
96
448
R4110
NOMESCO Finland
Physiotherapy
2.3
10.5
118
627
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
12.5
10.5
18
15
LWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gynaecological surgery
33.6
10.4
13
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
10.5
10.1
19
19
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
10.1
35
83
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
10.0
162
1006
WX002
NOMESCO Finland
Sedation and analgesia
2.5
9.8
86
402
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.9
9.8
40
111
Z3231
NOMESCO Finland
Registered nurse
2.2
9.7
118
645
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.7
9.7
24
38
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
9.6
141
837
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
9.5
186
1240
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
9.4
85
404
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
9.3
56
207
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
9.2
46
151
H02AB06
ATC
prednisolone; systemic
2.0
9.2
180
1198
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
9.1
76
344
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
9.1
42
130
ZXA00
NOMESCO Finland
Right side
2.1
9.0
120
679
UJF32
NOMESCO Finland
Coloscopy
2.2
8.8
109
599
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
8.8
133
795
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.3
8.6
22
37
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
8.5
100
535
L04AX01
ATC
azathioprine; systemic
4.5
8.4
29
69
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.9
8.2
33
91
J01DB01
ATC
cefalexin; oral
2.1
8.0
299
2475
ZXA05
NOMESCO Finland
Left side
2.1
8.0
108
610
A46
ICD-10 Finland
Erysipelas
2.6
7.9
59
250
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
13.4
7.9
13
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
7.9
131
803
Z2221
NOMESCO Finland
Medical doctor
2.0
7.9
114
662
SPAT1255
SPAT
Intravenous administration of medicine
3.9
7.9
31
84
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.8
7.8
21
38
A02BA02
ATC
ranitidine; systemic
2.2
7.8
86
447
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
7.8
43
150
Z2446
NOMESCO Finland
Social worker
3.5
7.7
35
107
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.5
7.7
26
61
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
7.7
37
119
JAH00
NOMESCO Finland
Laparotomy
5.6
7.6
21
39
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.3
7.6
14
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
7.6
65
298
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.7
7.4
24
54
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.9
7.4
46
175
JN4BD
NOMESCO Finland
Extensive body CT
2.7
7.3
50
202
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.1
7.3
41
145
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.0
7.3
19
33
B01AA03
ATC
warfarin; systemic
2.2
7.3
84
443
UJF30
NOMESCO Finland
Ileoscopy through colon
2.8
7.2
45
172
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
7.1
38
132
N03AX16
ATC
pregabalin; oral
2.1
7.1
97
547
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
7.1
49
200
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.5
7.0
17
27
A06AD11
ATC
lactulose; oral
2.3
7.0
66
316
B01AB05
ATC
enoxaparin; parenteral
2.0
7.0
114
689
ZXE00
NOMESCO Finland
One hour or less
1.8
7.0
149
993
GD1AD
NOMESCO Finland
Thorax CT examination
4.6
7.0
23
53
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.6
6.8
29
85
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
6.6
70
353
N02AA05
ATC
oxycodone; systemic
2.3
6.6
64
311
A07AA02
ATC
nystatin; oral
3.4
6.6
31
98
J01CF02
ATC
cloxacillin; systemic
6.4
6.5
16
26
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
6.5
33
111
X58
ICD-10 Finland
Exposure to other specified factors
2.4
6.5
54
245
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
5.1
6.4
19
39
WX110
NOMESCO Finland
Local anesthesy
1.8
6.4
244
1934
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.3
6.4
22
53
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
6.4
28
84
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.1
6.3
33
113
AA1AD
NOMESCO Finland
CT of head and brain
2.0
6.3
90
514
6BA02
NOMESCO Finland
NA
18.4
6.3
9
5
NHW10
NOMESCO Finland
Reoperation for deep infection in in surgery of ankle or foot
+∞
6.3
6
*
D81.6
ICD-10 Finland
Major histocompatibility complex class I deficiency
+∞
6.3
6
*
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
+∞
6.3
6
*
JAH33
NOMESCO Finland
Opening of laparostomy
+∞
6.3
6
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
6.3
6
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
6.3
6
*
QDA10
NOMESCO Finland
Incision of skin of lower limb
27.2
6.2
8
*
J01XX08
ATC
linezolid; systemic
27.2
6.2
8
*
ZX120
NOMESCO Finland
Intravenous
2.6
6.2
44
182
WX892
NOMESCO Finland
Monitored bed care
3.0
6.2
35
124
L28
ICPC
Limited function/disability (L)
2.2
6.2
63
312
JAH01
NOMESCO Finland
Laparoscopy
3.7
6.1
25
71
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.3
6.1
21
51
J04AB02
ATC
rifampicin; systemic
10.3
6.1
11
11
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.7
6.1
19
42
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
6.0
81
451
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
6.0
55
258
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.8
6.0
24
67
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
16
15.20
25.55
3.6
2.1
%
12.8
10.3
—
17
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
16
14.50
23.83
3.7
2.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
26
25
11.06
23.80
3.8
1.8
e9/l
1.2
0.9
0.55
19
11
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
22
21
11.03
20.17
3.7
1.8
e6/l
566.3
599.0
0.06
17
16
(3007853) Bacteria identified in Skin by Aerobe culture
86
340
2.95
15.97
2.6
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
146
754
2.48
15.94
3.4
2.2
mg/l
3.0
3.1
0.09
130
650
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
45
6.36
15.80
8.6
5.5
iu/ml
1262.0
200.0
—
5
7
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
25
8.37
15.02
1.4
1.2
g/l
1.8
2.8
1.24
12
18
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
25
8.37
15.02
1.4
1.2
g/l
0.3
0.3
0.03
12
18
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
25
8.37
15.02
1.4
1.2
g/l
5.0
6.7
1.92
11
19
(4062490)
19
26
7.62
13.23
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
95
439
2.53
12.81
2.9
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
144
800
2.26
12.79
7.6
4.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
54
191
3.11
12.04
4.2
1.6
g/l
1.3
1.8
0.58
48
174
(3022948) Iron [Moles/volume] in Serum or Plasma
98
476
2.41
11.78
3.0
2.2
umol/l
12.2
13.1
0.45
89
435
(3024561) Albumin [Mass/volume] in Serum or Plasma
204
1334
2.09
11.65
8.0
4.5
g/l
34.6
35.5
1.51
195
1244
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
212
1407
2.09
11.62
12.3
6.0
mmol/l
1.2
1.2
0.02
191
1281
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
16
8
20.76
11.22
5.2
1.3
u/ml
656.0
790.9
—
16
8
(3004789) Transferrin [Mass/volume] in Serum or Plasma
90
430
2.41
11.17
3.0
2.2
g/l
2.4
2.3
0.49
82
396
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
40
5.49
10.70
1.4
1.3
g/l
0.3
0.6
1.32
14
32
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
49
178
3.00
10.41
1.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
221
1533
2.00
10.25
13.7
6.4
mmol/l
1.2
1.2
0.18
184
1293
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
412
2.35
10.14
3.6
2.3
%
20.3
22.4
0.62
74
359
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
26
64
4.28
9.86
3.0
1.2
mg/l
11.0
10.6
0.11
26
57
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
91
468
2.23
9.39
3.1
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
183
1230
1.90
8.92
2.3
2.0
pmol/l
93.6
95.2
0.15
109
616
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
53
218
2.65
8.92
2.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
106
594
2.07
8.72
4.6
3.4
ng/l
188.9
359.7
0.50
80
459
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
22
6.56
8.58
2.4
1.4
u/l
15.1
11.9
0.73
14
22
(3018418) pH of Serum or Plasma
149
951
1.91
8.39
6.9
3.7
ph
7.4
7.4
0.12
30
176
(3003458) Phosphate [Moles/volume] in Serum or Plasma
79
401
2.21
8.35
10.0
4.9
mmol/l
1.0
1.0
0.06
71
365
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
326
2.31
8.23
2.6
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
65
3.87
8.02
2.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
65
3.87
8.02
2.6
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
90
3.40
7.96
3.0
2.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
222
1626
1.83
7.92
9.4
5.6
umol/l
10.1
12.0
2.16
211
1547
(3027945) Reticulocytes/100 erythrocytes in Blood
68
333
2.26
7.82
3.5
2.8
%
1.8
1.8
0.05
62
300
(3012095) Magnesium [Moles/volume] in Serum or Plasma
88
481
2.07
7.65
6.3
3.2
mmol/l
0.8
0.8
0.75
80
455
(3013650) Neutrophils [#/volume] in Blood by Automated count
239
1802
1.82
7.64
16.8
8.7
e9/l
4.6
4.1
2.38
216
1568
(3006315) Basophils [#/volume] in Blood
211
1535
1.80
7.58
12.9
5.3
e9/l
0.0
0.0
0.03
185
1321
(3001604) Monocytes [#/volume] in Blood
210
1528
1.79
7.51
12.9
5.2
e9/l
0.6
0.6
1.77
185
1310
(3018010) Neutrophils/100 leukocytes in Blood
203
1464
1.79
7.47
12.6
5.2
%
59.1
57.0
1.60
197
1372
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
52
232
2.43
7.38
4.7
3.4
ng/l
96.0
79.9
0.64
46
208
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
0
+∞
7.31
2.1
0.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
214
1583
1.76
7.09
13.1
5.7
e9/l
0.2
0.2
0.09
190
1387
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
52
4.00
7.07
1.6
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
212
1566
1.76
7.04
13.0
5.3
e9/l
2.0
2.0
0.01
191
1381
(3006504) Eosinophils/100 leukocytes in Blood
197
1436
1.74
6.76
13.4
5.3
%
2.9
2.8
0.11
188
1333
(42870588) Differential panel, method unspecified - Blood
149
1004
1.77
6.74
13.2
5.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
332
2.15
6.70
2.7
1.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
198
1448
1.73
6.70
13.9
5.5
%
8.5
8.5
0.09
192
1355
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
45
4.14
6.69
2.4
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
188
1369
1.71
6.36
4.3
2.6
ug/l
152.6
115.2
1.14
176
1261
(3002030) Lymphocytes/100 leukocytes in Blood
200
1485
1.70
6.26
13.4
5.4
%
26.7
28.2
1.00
193
1382
(3000850) Epithelial cells [#/volume] in Urine
107
666
1.83
6.23
3.8
2.6
e6/l
5.2
5.5
0.18
96
594
(3023520) Reticulocytes [#/volume] in Blood
50
237
2.27
6.18
3.7
2.6
e9/l
71.0
70.9
0.00
36
187
(3009508) Creatinine [Moles/volume] in Urine
138
929
1.74
6.15
3.5
3.0
mmol/l
7.0
7.5
0.57
112
785
(3032080) INR in Blood by Coagulation assay
172
1235
1.69
6.04
15.7
8.2
inr
1.2
1.2
0.19
47
358
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
360
2.04
6.03
4.4
2.5
umol/l
4.9
8.2
2.76
59
311
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
79
3.17
6.03
5.1
2.5
u/ml
0.3
0.3
0.09
15
39
(3022096) Basophils/100 leukocytes in Blood
188
1393
1.66
5.79
13.7
5.4
%
0.6
0.7
1.12
182
1292
(44790049)
13
28
4.77
5.77
2.3
1.4
—
—
—
0
0
(44790048)
13
28
4.77
5.77
2.3
1.4
—
—
—
0
0
(44806118)
13
28
4.77
5.77
2.3
1.4
—
—
—
0
0
(44790047)
13
28
4.77
5.77
2.3
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
140
962
1.70
5.72
4.1
2.3
u/l
56.1
55.9
0.01
134
888
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
192
2.33
5.64
8.3
3.6
mmol/l
2.0
1.8
0.12
32
144
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
289
2408
1.74
5.57
14.7
6.8
u/l
83.1
79.5
0.70
276
2245
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
29
4.60
5.55
2.5
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
62
334
2.01
5.53
11.4
8.8
mmol/l
1.9
1.1
0.95
53
266
(36304419) Bacteria [Presence] in Urine
127
860
1.70
5.43
4.3
3.0
—
—
—
0
0
(3009343) pH of Capillary blood
43
204
2.24
5.31
8.4
3.5
ph
7.4
7.4
—
7
24
(3007164) IgA [Mass/volume] in Serum or Plasma
99
629
1.76
5.30
2.9
1.4
g/l
2.1
2.5
1.20
60
381
(3005322) IgE [Units/volume] in Serum or Plasma
41
191
2.28
5.28
1.7
1.2
u/ml
222.6
316.2
0.24
35
171
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
157
1132
1.64
5.24
5.2
3.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
35
4.11
5.21
2.7
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
94
591
1.77
5.21
1.9
1.7
nmol/l
1238.7
1224.0
0.04
68
440
(40758558) Short blood count panel - Blood
119
800
1.70
5.20
12.7
6.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
127
871
1.67
5.14
4.4
3.1
e6/l
0.2
0.5
2.31
107
662
(3042631) Mycobacterium sp identified in Specimen
12
27
4.55
5.07
4.0
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
88
2.84
5.04
1.8
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
349
1.92
4.87
1.8
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1286
1.60
4.86
3.8
2.2
nmol/l
78.8
76.8
0.38
154
1147
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
45
226
2.12
4.83
3.1
2.6
ng/l
154.4
190.5
0.35
40
206
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
24
4.69
4.81
2.5
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
10
9.18
4.80
2.3
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
79
2.89
4.79
2.5
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
60
336
1.93
4.78
11.7
8.7
kpa
5.3
5.1
1.26
55
320
(3027801) Oxygen [Partial pressure] in Arterial blood
60
336
1.93
4.78
11.6
8.7
kpa
12.0
12.1
0.05
55
323
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
38
3.78
4.68
2.6
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
5
14.21
4.59
2.7
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
228
1836
1.57
4.58
9.8
4.8
mmol/l
7.0
6.6
1.03
221
1708
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
70
2.96
4.56
1.5
2.1
g/l
130.2
128.0
0.10
13
48
(3012516) Albumin [Mass/volume] in Urine
124
869
1.62
4.52
4.1
3.0
mg/l
2024.5
273.7
1.14
81
553
(3037522) Nuclear Ab [Titer] in Serum
68
404
1.82
4.51
1.7
1.3
titre
431.1
543.7
0.30
18
93
(3025941) Bacteria identified in Stool by Culture
38
184
2.18
4.48
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
100
2.60
4.47
4.8
3.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
94
2.65
4.47
1.8
1.3
ug/g
296.5
300.6
0.04
17
58
(3019060) Gas panel - Arterial blood
40
198
2.13
4.46
8.0
6.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
50
270
1.97
4.43
13.8
4.1
mmol/l
1.9
2.1
0.11
35
215
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
35
3.81
4.40
3.4
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
97
643
1.67
4.39
4.2
2.7
mosm/kgh2o
529.9
558.5
0.67
89
559
(3023183) Ammonium ion [Moles/volume] in Plasma
18
61
3.04
4.34
1.7
3.4
umol/l
32.9
34.8
0.14
13
52
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
22
4.64
4.32
1.8
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
41
209
2.07
4.25
2.8
2.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
133
960
1.58
4.25
4.6
3.3
e6/l
22.9
127.6
0.91
111
742
(3036481) Cortisol [Moles/volume] in Serum or Plasma
52
289
1.92
4.24
4.3
1.8
nmol/l
324.7
383.4
1.38
47
261
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
46
3.35
4.23
5.0
2.4
e9/l
4.9
5.0
0.08
15
46
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
79
500
1.72
4.22
2.7
2.8
e6/l
0.7
1.1
1.11
43
284
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
62
2.99
4.22
1.9
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
67
406
1.78
4.16
2.0
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
176
2.15
4.15
2.2
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
274
2327
1.57
4.15
7.3
4.0
mm/h
16.2
12.0
4.42
259
2140
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
25
104
2.50
4.15
2.8
1.2
u/l
39.5
36.2
0.30
25
91
(3012544) pH of Venous blood
51
284
1.91
4.13
13.6
4.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
58
3.02
4.06
2.3
2.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
7
10.15
4.02
1.1
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
7
10.15
4.02
1.1
1.0
%
95.4
93.9
—
7
7
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
48
3.21
3.97
6.3
2.8
%
63.1
59.1
0.51
15
48
(3000991) Gas panel - Venous blood
46
251
1.94
3.96
21.7
8.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
128
931
1.55
3.90
2.4
2.0
u/l
185.5
193.2
0.04
118
878
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
24
102
2.44
3.82
2.3
2.0
ug/l
181.6
312.6
0.76
24
95
(40768797) Stomach Pathology biopsy report
67
417
1.73
3.79
1.5
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
5
12.15
3.77
3.2
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
46
257
1.89
3.70
3.2
2.3
ug/l
3.3
6.6
2.33
38
228
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
110
2.36
3.70
1.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
19
73
2.68
3.69
1.3
1.5
iu/ml
0.1
0.1
—
6
15
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
137
1023
1.52
3.67
5.0
2.9
u/l
37.9
31.3
1.02
132
979
(3018095) Leukocytes [#/volume] in Urine
149
1136
1.50
3.60
5.3
3.8
e6/l
171.3
115.6
0.18
117
803
(3021589) Normoblasts [#/volume] in Blood
175
1379
1.48
3.59
18.4
9.0
e9/l
0.0
0.0
0.35
147
1127
(3021960) Folate [Moles/volume] in Serum or Plasma
104
734
1.56
3.58
1.8
1.6
nmol/l
18.8
21.2
1.16
94
611
(3014111) Lactate [Moles/volume] in Serum or Plasma
47
268
1.85
3.56
16.6
7.3
mmol/l
1.2
1.3
0.69
42
252
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
291
1.82
3.55
3.2
2.2
u/l
37.2
28.7
0.53
45
241
(3044640) Blood type and Crossmatch panel - Blood
133
993
1.51
3.54
3.5
2.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
9
17
5.39
3.53
2.4
6.8
—
63.0
—
0
5
(3023419) Bacteria identified in Sputum by Culture
13
41
3.24
3.52
3.5
2.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
6
10.13
3.51
2.0
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
669
1.57
3.49
2.6
1.8
mg/l
1.3
1.2
0.16
75
528
(3017143) Hepatitis C virus Ab [Presence] in Serum
54
324
1.77
3.47
2.1
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
162
1265
1.47
3.44
2.4
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
197
1.97
3.43
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
73
479
1.64
3.39
3.3
3.1
e6/l
2.9
2.8
0.04
38
265
(3026389) Candida sp identified in Specimen by Organism specific culture
12
37
3.31
3.37
1.1
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
26
122
2.21
3.34
1.9
2.1
g/l
1.8
1.5
0.61
21
107
(3051611) Lipemic interference index of Serum or Plasma
11
33
3.40
3.21
3.2
3.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
61
2.69
3.17
5.3
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
44
3.02
3.16
3.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
50
2.87
3.12
3.3
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
122
916
1.48
3.10
4.5
3.7
mg/mmol
19.2
8.4
1.11
76
572
(46235355) HIV 1 and 2 tests - Meaningful Use set
72
482
1.60
3.08
1.8
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
34
3.30
3.08
1.4
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
98
705
1.52
3.06
1.3
1.3
u/ml
1.0
1.5
0.48
28
203
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
179
1449
1.43
3.05
7.0
3.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
35
191
1.91
3.04
2.9
2.5
nmol/l
10.5
12.5
0.77
30
173
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
12
5.92
3.03
7.9
3.2
umol/l
21.4
31.9
—
7
12
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
21
4.36
3.01
1.4
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
21
4.36
3.01
3.7
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
42
245
1.80
2.97
7.7
3.8
%
1.1
0.9
0.22
17
80
(3026493) Urate [Moles/volume] in Serum or Plasma
104
763
1.49
2.95
4.7
2.4
umol/l
346.1
5781.9
2.61
92
649
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
46
2.89
2.94
1.4
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
52
2.75
2.92
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
22
4.16
2.90
2.3
3.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
9
6.75
2.87
2.7
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
120
910
1.46
2.87
3.9
3.0
ng/l
1853.2
1341.6
0.65
108
773
(3002179) Metamyelocytes/100 leukocytes in Blood
38
218
1.82
2.84
7.3
3.8
%
0.3
0.3
0.01
12
50
(3037756) Immunofixation for Serum or Plasma
16
65
2.52
2.82
2.1
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
18
4.51
2.81
1.5
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
18
4.51
2.81
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
41
242
1.77
2.80
4.5
3.8
mmol/l
1.2
1.2
0.88
36
216
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
6
8.42
2.75
1.2
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
66
2.48
2.74
2.9
2.2
%
16.3
15.7
—
9
30
(3009261) Glucose [Presence] in Urine by Test strip
190
1575
1.40
2.74
4.7
3.6
estimate
0.0
0.0
0.50
39
283
(3035350) Ketones [Presence] in Urine by Test strip
187
1549
1.39
2.69
4.8
3.6
estimate
0.0
0.0
0.00
38
293
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
24
3.81
2.68
1.9
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
39
230
1.77
2.68
7.9
4.0
%
0.1
0.1
0.05
15
71
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
10
32
3.18
2.66
1.3
1.2
u/l
67.2
58.0
—
5
23
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
317
1.66
2.66
5.0
3.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
28
150
1.93
2.59
11.1
3.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
20
4.06
2.58
1.5
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
11
5.52
2.55
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
16
4.43
2.48
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
16
4.43
2.48
1.6
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
214
1.75
2.42
8.1
4.1
%
0.0
0.1
0.49
13
57
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
17
4.17
2.37
1.1
3.8
%
90.3
100.4
—
7
17
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
750
1.43
2.34
3.6
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
247
2170
1.37
2.34
7.2
4.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
185
1555
1.36
2.33
6.0
4.9
estimate
0.0
0.0
0.00
38
292
(3012441) Differential panel - Pleural fluid
9
28
3.26
2.32
1.9
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
106
2.04
2.30
3.3
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
79
2.20
2.28
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
18
3.94
2.26
2.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
60
2.38
2.24
2.0
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
151
1.85
2.22
17.2
12.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
48
2.55
2.20
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
67
2.29
2.20
29.0
5.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
24
3.38
2.19
1.4
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
55
376
1.54
2.16
2.3
2.2
ug/g
152.2
142.0
0.09
44
300
(40760888) Immunoglobulin light chains.free panel - Serum
15
68
2.25
2.13
5.9
5.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
37
2.75
2.12
1.5
1.1
g/l
1.5
1.4
—
10
31
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
25
3.24
2.10
1.4
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
25
3.24
2.10
2.5
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
133
1.86
2.04
2.0
1.8
—
—
—
0
0
(4035726)
42
274
1.60
2.02
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
284
3074
0.73
2.02
4.8
4.4
mmol/l
1.4
1.5
2.55
255
2827
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
57
2.32
2.00
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
27
3.00
1.94
2.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
106
1.93
1.94
6.2
4.2
g/l
2.1
0.3
0.49
12
45
(3020891) Body temperature
22
121
1.87
1.92
4.6
5.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
65
2.20
1.90
1.8
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
206
1.66
1.90
1.6
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
100
1.95
1.89
1.4
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
28
2.89
1.87
1.9
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
115
1.87
1.86
3.4
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
52
364
1.49
1.85
1.2
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
287
3090
0.74
1.85
4.8
4.4
mmol/l
4.5
4.7
3.07
263
2862
(3015377) Calcium [Moles/volume] in Serum or Plasma
131
1076
1.32
1.84
4.7
3.2
mmol/l
2.4
2.4
1.01
117
937
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
294
3152
0.74
1.81
5.3
4.9
mmol/l
2.6
2.8
2.46
265
2895
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
8
29
2.79
1.80
1.0
1.2
—
79.0
—
0
6
(21494434) Karyotype in Bone marrow
8
29
2.79
1.80
1.6
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
60
2.21
1.79
1.8
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
102
1.91
1.79
1.4
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
47
2.38
1.79
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
90
1130
0.74
1.78
3.1
2.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
74
2.07
1.77
1.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
56
402
1.46
1.76
1.5
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
18
3.37
1.75
1.3
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
36
2.53
1.75
2.1
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
103
1.89
1.75
1.4
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
3.9
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
13
3.88
1.72
4.0
2.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
19
3.19
1.66
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
69
2.07
1.66
1.9
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
312
0.56
1.66
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
49
2.28
1.65
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
128
1.76
1.64
1.4
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
171
0.46
1.62
2.8
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
721
1.34
1.62
4.2
3.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
10
43
2.36
1.61
1.8
1.4
nmol/l
0.2
0.4
—
10
35
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
275
2961
0.77
1.61
4.1
3.9
mmol/l
1.5
1.3
4.08
248
2708
(3044927) Protein electrophoresis panel - Urine
8
32
2.53
1.60
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
26
2.72
1.58
3.7
3.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
33
2.45
1.54
5.8
4.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
15
3.36
1.53
1.2
2.9
%
140.0
127.3
—
5
15
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
4.2
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
155
1.65
1.51
2.5
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
58
2.10
1.50
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
58
2.10
1.50
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
37
2.46
1.49
2.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
37
2.46
1.49
2.1
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
37
2.46
1.49
1.4
2.3
ug/l
23.8
15.1
—
9
37
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
37
2.46
1.49
2.1
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
117
1.75
1.48
3.3
2.0
g/l
3.0
3.0
0.02
14
96
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
38
2.40
1.46
2.1
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
38
2.40
1.46
2.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
83
660
1.33
1.44
9.8
4.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
82
651
1.33
1.44
1.8
1.7
pmol/l
436.9
7246824.4
0.50
67
552
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
16
3.15
1.44
4.2
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
39
2.34
1.44
2.0
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
126
1.70
1.43
3.1
1.9
g/l
7.6
7.5
0.07
14
99
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
126
1.70
1.43
3.1
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
126
1.70
1.43
3.1
1.9
g/l
3.2
3.8
1.40
14
94
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
20
119
1.72
1.40
1.3
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
265
2437
1.26
1.39
4.7
3.9
pmol/l
14.7
14.7
0.05
244
2210
(3008898) HLA-B27 [Presence]
20
120
1.70
1.37
1.2
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
17
2.96
1.36
1.0
3.3
nmol/l
58.2
88.7
—
5
17
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
16
90
1.81
1.35
5.6
4.5
mg/l
24.1
26.4
0.17
11
70
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
47
2.16
1.34
2.2
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
115
964
1.27
1.34
3.8
3.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
139
1195
1.25
1.31
5.6
3.6
ng/l
26.6
40.7
1.32
100
817
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
43
2.12
1.31
1.1
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
1.8
1.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
24
2.52
1.31
1.8
1.3
u/l
230.7
270.4
—
6
24
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
24
2.52
1.31
1.8
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
4.2
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
92
1.77
1.27
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
68
536
1.32
1.26
1.4
1.3
iu/ml
47.4
35.7
0.21
33
168
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
70
1.89
1.25
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
286
0.61
1.23
1.7
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
16
93
1.75
1.23
1.8
1.5
mu/l
341.6
294.1
0.42
16
85
(3025130) Human papilloma virus identified in Specimen
8
39
2.07
1.16
1.4
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
20
2.52
1.15
1.8
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
51
1.99
1.12
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
21
2.40
1.09
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
21
2.40
1.09
1.4
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
89
1.71
1.09
1.5
1.3
—
—
—
0
0
(4010399)
33
237
1.43
1.09
1.7
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
33
2.14
1.06
2.1
1.5
pg
30.9
32.2
—
7
33
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
215
1968
1.20
1.04
3.5
3.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
46
1.98
1.04
1.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
34
2.08
1.03
4.3
3.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
91
1.67
1.02
1.5
1.3
—
—
—
0
0
(4146454)
5
23
2.19
0.98
5.2
2.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
23
2.19
0.98
6.4
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
36
1.96
0.97
2.9
2.4
%
14.2
13.4
—
7
36
(3045424) Erythrocytes [Presence] in Urine
10
54
1.87
0.97
1.7
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
69
831
0.79
0.96
1.5
1.4
—
—
—
0
0
(3019225) pH of Specimen
37
278
1.36
0.96
7.5
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
49
386
1.31
0.94
13.2
6.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
27
2.24
0.94
2.7
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
168
1.46
0.92
1.4
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
28
2.16
0.92
4.7
7.3
%
9.8
11.2
—
6
28
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
102
0.48
0.90
1.2
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
29
212
1.40
0.89
4.1
2.4
e9/l
6.0
4.0
1.04
21
167
(3044889) 12 lead EKG panel
238
2217
1.18
0.89
5.0
3.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
82
696
1.22
0.86
5.2
4.0
kg/l
1.0
1.0
—
10
93
(3000764) Benzodiazepines [Presence] in Urine
15
96
1.58
0.85
1.5
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
45
1.79
0.84
1.5
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
328
3153
1.23
0.83
31.7
13.6
mg/l
26.7
23.2
1.11
290
2476
(3028300) Cannabinoids [Presence] in Urine
15
97
1.57
0.82
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
97
1.57
0.82
1.5
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(4281824)
6
33
1.83
0.79
1.5
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
253
1.33
0.78
5.9
3.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
334
1.29
0.77
4.3
3.8
ug/l
3.5
40.1
0.95
32
287
(36660697) Celiac disease serology panel - Serum
32
246
1.33
0.75
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
34
264
1.31
0.74
7.3
3.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
39
1.81
0.73
1.3
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
3.7
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
26
1.93
0.71
1.0
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.71
1.2
1.0
—
—
—
0
0
(4024509)
5
26
1.93
0.71
2.0
1.4
—
—
—
0
0
(3013512) EKG study
103
911
1.18
0.70
4.6
3.6
—
—
—
0
0
(4306422)
7
42
1.68
0.68
1.1
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
28
1.80
0.66
2.0
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
103
1.47
0.66
2.3
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
302
2902
1.17
0.65
6.0
4.7
mu/l
2.0
2.3
0.24
278
2638
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
63
1.60
0.62
2.2
2.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
50
1.61
0.61
1.5
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
276
2643
1.15
0.59
34.7
17.1
%
14.1
13.7
4.75
271
2595
(4034850)
7
113
0.61
0.59
12.1
10.7
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
245.1
—
0
12
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
33.1
—
0
12
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
542.8
—
0
12
(3023103) Potassium [Moles/volume] in Serum or Plasma
334
3245
1.18
0.58
33.8
15.8
mmol/l
4.0
4.0
0.38
328
3154
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
195
0.71
0.57
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
60
1.51
0.54
1.9
2.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
333
3239
1.17
0.54
33.7
15.7
mmol/l
139.4
139.7
1.15
326
3153
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
845
1.15
0.53
1.8
1.7
mmol/l
1.4
1.4
0.20
75
722
(3010813) Leukocytes [#/volume] in Blood
343
3502
0.85
0.49
41.6
20.1
e9/l
7.4
6.6
3.78
336
3400
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
296
3052
0.88
0.48
5.4
4.5
mmol/l
6.0
5.9
0.58
271
2799
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
42
492
0.84
0.48
2.7
3.0
ug/l
1.2
0.7
0.31
30
311
(3024731) MCV [Entitic volume]
343
3501
0.85
0.48
41.4
20.0
fl
90.8
91.1
0.48
338
3448
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
47
1.50
0.48
1.3
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
289
2980
0.89
0.45
23.8
12.7
ml/min/173m2
81.7
80.4
0.42
258
2435
(3041096) Erythrocytes [Presence] in Urine by Automated
95
867
1.13
0.43
4.9
3.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
31
1.62
0.43
2.0
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
131
1219
1.11
0.42
5.4
3.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
96
1.37
0.42
1.5
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
216
2064
1.10
0.41
4.5
3.0
u/l
61.7
46.2
2.09
196
1940
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
1.2
—
0
9
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
223.0
—
0
16
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
344
3503
0.87
0.40
41.7
20.1
g/l
129.2
134.6
7.74
339
3446
(3015183) Erythrocyte sedimentation rate
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
61
1.32
0.39
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
344
3502
0.87
0.39
41.5
20.1
e12/l
4.3
4.5
3.66
337
3399
(3044941) Cell count panel - Synovial fluid
5
35
1.43
0.39
1.4
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
243
1.21
0.39
2.9
2.6
ml/min/173m2
54.8
64.1
0.60
13
100
(3035941) MCH [Entitic mass]
344
3501
0.87
0.38
41.3
20.0
pg
30.1
30.3
1.33
339
3448
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
283
2910
0.90
0.38
6.7
5.5
mmol/mol
41.2
39.6
1.70
269
2706
(3007461) Platelets [#/volume] in Blood
344
3500
0.87
0.37
41.5
20.1
e9/l
255.5
251.0
0.55
336
3411
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
37
1.36
0.37
2.0
3.2
nmol/l
2.5
3.2
—
5
37
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
70
1.29
0.37
1.3
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
41
1.47
0.36
1.3
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
42
1.44
0.35
1.3
1.3
nmol/l
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
46
519
0.87
0.35
1.8
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
67
607
1.12
0.35
4.0
2.7
mmol/l
2.5
2.5
1.37
55
533
(3049717) Cytology report of Urine Cyto stain
16
127
1.27
0.34
2.1
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
58
523
1.13
0.33
1.4
1.3
u/ml
18.1
12.0
0.17
19
204
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
252
0.82
0.33
2.0
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
34
390
0.86
0.33
6.0
4.4
%
32.2
31.9
0.06
24
256
(3023511) Choriogonadotropin [Units/volume] in Urine
6
47
1.28
0.32
1.7
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
53
1.33
0.31
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
327
1.15
0.29
1.9
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
331
3362
0.91
0.27
19.0
9.7
u/l
27.0
25.0
1.61
322
3243
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
62
673
0.91
0.26
4.7
4.4
%
20.0
20.4
0.07
30
306
(3029937) Albumin [Presence] in Urine by Test strip
92
864
1.08
0.25
6.8
4.0
estimate
0.0
0.0
0.00
39
287
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
96
1.26
0.25
1.2
1.1
—
9.2
—
0
12
(1761482) Bacteria [#/volume] in Urine by Culture
6
81
0.74
0.24
2.2
4.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
38
1.32
0.23
1.4
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
39
1.29
0.23
1.4
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
40
1.25
0.22
4.8
2.9
u/ml
26.3
54.8
—
5
40
(3000330) Specific gravity of Urine by Test strip
17
144
1.19
0.22
2.2
3.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
107
1.22
0.22
1.6
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
43
1.16
0.21
1.2
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
291
2859
1.07
0.20
30.7
14.9
%
38.7
39.8
1.27
200
2118
(4027681)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
49
1.23
0.20
1.7
1.3
mmol/l
7.8
7.8
—
6
30
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
52
1.16
0.19
1.2
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
53
1.13
0.18
1.3
1.2
u/l
723.9
16.1
—
6
47
(3002523) Influenza virus A Ag [Presence] in Specimen
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
157
1.15
0.17
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
81
849
0.94
0.16
5.3
5.0
ug/l
4.8
3.2
0.39
70
756
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
111
1.18
0.16
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
282
0.92
0.12
2.0
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
203
1.09
0.10
2.5
2.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
87
1.15
0.09
2.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
155
0.90
0.09
1.7
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
78
1.03
0.07
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
(4094501)
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
232
0.95
0.05
1.9
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
280
1.04
0.03
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
28
290
0.96
0.03
2.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
118
0.93
0.03
1.7
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
107
0.93
0.02
1.3
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
54
534
1.01
0.00
1.6
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
329
3296
0.99
0.00
26.8
12.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
225
0.98
0.00
1.4
1.2
iu/ml
45.5
169.1
—
10
91
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
104
0.96
0.00
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
13
134
0.97
0.00
1.1
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.4
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
9.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
49
1.02
0.00
2.0
1.5
u/l
35.4
29.4
—
5
42
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
59
0.85
0.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
59
0.85
0.00
1.4
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.8
—
0
7
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
59
0.85
0.00
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.1
—
8.1
—
0
9
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
8.5
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
51
0.98
0.00
1.0
1.1
—
1.7
—
0
21
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
59
0.85
0.00
1.4
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
7
0.00
0.00
0.0
2.9
—
84.3
—
0
7
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_COMBIMMUDEF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COMBIMMUDEF | 1.981 [1.72, 2.29] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.207 |
During the follow-up period (1.1.1998 — 31.12.2019), 454 out of 1489 females with D3_COMBIMMUDEF died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COMBIMMUDEF | 2.256 [1.92, 2.65] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 516 out of 1183 males with D3_COMBIMMUDEF died.
Mortality risk
Mortality risk for people of age
years, who have D3_COMBIMMUDEF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.171% | 0.394% |
| 5 | 1.141% | 2.075% |
| 10 | 2.912% | 5.699% |
| 15 | 5.574% | 11.202% |
| 20 | 9.77% | 18.871% |
Relationships between endpoints
↥Index endpoint: D3_COMBIMMUDEF – Combined immunodeficiencies
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data